Arcadia Biosciences, Inc. (RKDA) financial statements (2022 and earlier)

Company profile

Business Address 202 COUSTEAU PLACE
DAVIS, 95618
State of Incorp. DE
Fiscal Year End December 31
SIC 01 - Agricultural Production Crops (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments28,68535,52643,97751,93625,66710,20115,595
Cash and cash equivalents28,68535,52643,97732,84814,04210,20114,995
Short-term investments   19,08811,625 600
Receivables1,3701,4531,1471,1131,406373403
Inventory, net of allowances, customer advances and progress billings4,4335,4473,8972,6633,8129,4168,772
Inventory4,4335,4473,8972,6633,8129,4168,772
Other undisclosed current assets9001,4081,8959018111,2041,326
Total current assets:35,38843,83450,91656,61331,69621,19426,096
Noncurrent Assets
Inventory, Noncurrent2,4943,5393,8904,2903,485461658
Operating lease, right-of-use asset3,0813,4866,3605,6365,8266,0135,598
Property, plant and equipment2,2912,6343,7403,4803,5393,4843,403
Intangible assets, net (including goodwill)4845,5535,716758778701 
Goodwill 1,6481,648408408301 
Intangible assets, net (excluding goodwill)4843,9054,068350370400 
Restricted cash and investments    2,0012,0012,000
Other noncurrent assets18018217623232323
Total noncurrent assets:8,53015,39419,88214,18715,65212,68311,682
TOTAL ASSETS:43,91859,22870,79870,80047,34833,87737,778
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,6385,0045,1893,4184,1056,7116,937
Accounts payable1,411   726  
Accrued liabilities271   592  
Employee-related liabilities1,606   1,489  
Other undisclosed accounts payable and accrued liabilities3505,0045,1893,4181,2986,7116,937
Deferred revenue  63638  
Debt 361,1401,1411,141705519
Due to related parties64513326802922
Other liabilities264264264264263263263
Other undisclosed current liabilities1,0741,134962705717700623
Total current liabilities:5,0406,4897,6515,6176,3148,4088,364
Noncurrent Liabilities
Long-term debt and lease obligation2,2202,6405,8145,3247,4948,1227,962
Long-term debt, excluding current maturities 7887962,1052,5482,742
Operating lease, liability2,2202,5625,7275,2285,3895,5745,220
Liabilities, other than long-term debt2,0702,1402,1402,1402,2802,2802,000
Other liabilities2,0702,1402,1402,1402,2802,2802,000
Other undisclosed noncurrent liabilities3,3927,73612,51412,0162,7083,0655,836
Total noncurrent liabilities:7,68212,51620,46819,48012,48213,46715,798
Total liabilities:12,72219,00528,11925,09718,79621,87524,162
Stockholders' equity
Stockholders' equity attributable to parent31,09339,84541,64044,50327,72511,28012,120
Common stock63636362545150
Additional paid in capital257,515257,009256,616254,208239,496231,954226,405
Accumulated other comprehensive loss (24)(12)    
Accumulated deficit(226,485)(217,203)(215,027)(209,767)(211,825)(220,725)(214,335)
Stockholders' equity attributable to noncontrolling interest1033781,0391,2008277221,496
Total stockholders' equity:31,19640,22342,67945,70328,55212,00213,616
TOTAL LIABILITIES AND EQUITY:43,91859,22870,79870,80047,34833,87737,778

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues2,1712,3761,4058287,130314281
Cost of revenue(11,590)(818)(823)(160)   
Cost of goods and services sold (818)(823)(160)   
Other undisclosed gross profit    (4,311)  
Gross profit:(9,419)1,5585826682,819314281
Operating expenses(2,585)(11,089)(9,088)(6,154)339(7,895)(7,157)
Other undisclosed operating income (loss)(1,800)8188241604,311  
Operating income (loss):(13,804)(8,713)(7,682)(5,326)7,469(7,581)(6,876)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(100)(7)2,7597,463657 10
Interest and debt expense3(15)(1)(9)(15)(705)41
Income (loss) from continuing operations before equity method investments, income taxes:(13,901)(8,735)(4,924)2,1288,111(8,286)(6,825)
Other undisclosed income from continuing operations before income taxes9,300   6,570  
Income (loss) from continuing operations before income taxes:(4,601)(8,735)(4,924)2,12814,681(8,286)(6,825)
Income tax expense (benefit)(1)(1)  139(9)10
Income (loss) before gain (loss) on sale of properties:(4,602)(8,736)(4,924)2,12814,820(8,295)(6,815)
Other undisclosed net income (loss)(4,955)5,900(498)(447)(6,212)1,130(3,079)
Net income (loss):(9,557)(2,836)(5,422)1,6818,608(7,165)(9,894)
Net income attributable to noncontrolling interest275661161377290774205
Other undisclosed net income attributable to parent   0   
Net income (loss) available to common stockholders, diluted:(9,282)(2,175)(5,261)2,0588,898(6,391)(9,689)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(9,557)(2,836)(5,422)1,6818,608(7,165)(9,894)
Other comprehensive loss (12)(12)    
Other undisclosed comprehensive income24      
Comprehensive income (loss):(9,533)(2,848)(5,434)1,6818,608(7,165)(9,894)
Comprehensive income, net of tax, attributable to noncontrolling interest275661161377290774205
Other undisclosed comprehensive income, net of tax, attributable to parent   0   
Comprehensive income (loss), net of tax, attributable to parent:(9,258)(2,187)(5,273)2,0588,898(6,391)(9,689)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: